Home › Funds › Eversept Partners, LP › HCA
Eversept Partners, LP position in HCA
HCA Healthcare Inc · Health Care
Eversept Partners, LP reported holding 98,252 shares of HCA (HCA Healthcare Inc) in its Q2 2026 13F filing — a position valued at US$38.3M, representing 2.00% of its reported portfolio and ranking #14 among its reported holdings. Eversept Partners, LP has disclosed HCA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's HCA position evolved
Eversept Partners, LP first disclosed a stake in HCA in Q3 2023 at 110,073 shares (US$27.1M). The position peaked in Q4 2024 at 175,808 shares, worth US$52.8M. Across 12 filings, Eversept Partners, LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 98,252 shares valued at US$38.3M — an increase of 19,023 shares quarter over quarter.. Notable position changes include a 30% increase in Q2 2024 (shares rose 26% over the following quarter), a 36% increase in Q4 2024 (shares rose 15% over the following quarter), a 34% trim in Q2 2025 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 110.07K | $27.08M | New |
| Q4 2023 | 114.81K | $31.08M | Add |
| Q1 2024 | 103.82K | $34.63M | Reduce |
| Q2 2024 | 135.48K | $43.53M | Add |
| Q3 2024 | 129.08K | $52.46M | Reduce |
| Q4 2024 | 175.81K | $52.77M | Add |
| Q1 2025 | 152.50K | $52.70M | Reduce |
| Q2 2025 | 99.98K | $38.30M | Reduce |
| Q3 2025 | 111.70K | $47.61M | Add |
| Q4 2025 | 95.87K | $44.76M | Reduce |
| Q1 2026 | 79.23K | $37.49M | Reduce |
| Q2 2026 | 98.25K | $38.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCA and 13F data
HCA (HCA Healthcare Inc) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.44B), First Eagle Investment Management (US$1.28B), Arrowstreet Capital (US$861.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCA
- Sanders Capital, LLC 8.83M sh · $3.44B · Q2 2026
- First Eagle Investment Management 3.30M sh · $1.28B · Q2 2026
- Arrowstreet Capital 2.21M sh · $861.46M · Q2 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.43M sh · $553.70M · Q2 2026
- Crake Asset Management LLP 1.15M sh · $449.07M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held HCA?
Eversept Partners, LP has disclosed HCA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Eversept Partners, LP's current position in HCA?
As of Q2 2026, Eversept Partners, LP holds 98.25K shares of HCA (HCA Healthcare Inc), valued at $38.31M, representing 2.00% of its reported portfolio and ranking #14.
Has Eversept Partners, LP been buying or selling HCA?
In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in HCA. The position peaked in Q4 2024 at 175.81K shares.
Which other funds hold HCA?
Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.